The levels of the cytokines IL-6, IL-10, and GM-CSF, as well as the levels of the chemokine CCL2, were analyzed in the plasma of 27 patients with meningiomas (since one case had an undetermined subtype). This evidence concerns the gene CSF2 and meningioma.